B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Interleukin-23 signaling

REACTOME PATHWAY
Reactome: R-HSA-90209334 genes25 compounds

The Interleukin-23 signaling pathway (Reactome ID: R-HSA-9020933) involves 4 genes and is affected by 25 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

JAK2P4HBSTAT3TYK2

Compounds Affecting Interleukin-23 signaling

#CompoundTargets HitStudies
1Azauridine300
2Cladribine297
3Dasatinib299
4Methylene Blue200
52-Methoxyestradiol300
6Astemizole Antihistamine drug now withdrawn from280
7Azathioprine300
8Calcitriol300
9Camptothecin300
10Cytarabine297
11dihydrorotenone13
12Podophyllotoxin14
13streptonigrin299
14Trifluridine295
15Tripterygium300
16Crizotinib298
17Methotrexate289
18Axitinib298
19pictilisib25
20sp600125117
21Niclosamide299
22Fingolimod Hydrochloride56
23Celecoxib295
24juglone hydroxylase [Supplementary Concept] catalyzes279
25Equilin216

About the Interleukin-23 signaling Pathway

The Interleukin-23 signaling pathway is catalogued in Reactome (ID: R-HSA-9020933) and involves 4 genes. In the BiohacksAI corpus, 25 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include JAK2, P4HB, STAT3, TYK2.